drugset / Trial / NCT05008042
Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia
Phase 1/2
Completed
40 enrolled
Linnaeus University
Karolinska Institutet · collabKronoberg County Council · collabLandstinget i Kalmar Län · collabRegion Östergötland · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Fibromyalgia causes long term pain where mostly women are affected. It is not entirely clear how vitamin B12 affects the human pain system, there are however many primary studies that indicate different interesting approaches. Considering that the receptor of NMDA is involved in both long-term pain and vitamin B12 deficiency its of most importance to evaluate whether vitamin B12 decreases the pain sensitivity and the experience of pain i.e hyperalgesia and allodynia, at persons with fibromyalgia.The aim of this study is therefore to evaluate the effect of Mecobalamin (vitamin B12), and describe lived experiences of pain, health, suffering and well-being in women with diagnosed fibromyalgia.
Timeline
- Start
- 2019-02-06
- Primary completion
- 2024-03-26
- Completion
- 2024-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | methylcobalamin | Small molecule | 10 mg | Intramuscular |